. HIF-1 mediates hypoxia-induced invadopodia formation. (A) Percentage of SCC61 cells forming invadopodia after transfection with control (C) or HIF-1 siRNAs 1 and 2 and growth under or normoxia or hypoxia for 16 h, n = 3. *, P < 0.005. (B) qPCR analysis of GLUT-1 mRNA in SCC61 cells transfected with control or HIF-1 siRNAs 1 and 2, measured after 16 h of normoxia or hypoxia. Means ± SD for GLUT1 mRNA levels normalized to Actin mRNA are represented. n = 2. *, P < 0.01. (C) Percentage of SCC61 cells forming invadopodia after treatment with the HIF-1 inhibitor Echinomycin for 16 h in normoxia or hypoxia, n = 2. *, P < 0.01. (D) Percentage of PANC-1 or BxPC3 cells forming invadopodia after treatment with DAPT or same volume of vehicle for 16 h in normoxia or hypoxia, n = 3 for each cell line. *, P < 0.05; **, P < 0.005. (E) Percentage of SCC61 cells forming invadopodia after treatment with the indicated micromolar concentrations of compound E (CompE) in normoxia or hypoxia for 16 h, n = 2. *, P < 0.01; **, P < 0.005; ***, P < 1 × 10 7 . (F) Percentage of BxPC3 cells forming invadopodia after treatment the indicated concentration of compound E or corresponding volume of vehicle in normoxia or hypoxia for 16 h, n = 3. *, P < 5 × 10 -5 ; **, P < 3 × 10 10 . Histograms represent means ± SEM. Percentage of H1792 cells stably expressing shRNA control or shRNAs targeting ADAM12 (1 and 2) that form invadopodia after 16 h in normoxia or hypoxia, n = 3. *, P < 0.05; **, P < 0.01. (right) qPCR analysis of ADAM12 mRNA in H1792 cells stably expressing control or ADAM12 shRNAs 1 or 2. Means ± SD for ADAM12 mRNA levels normalized to 18S rRNA mRNA are represented, n = 2. *, P < 0.01; **, P < 0.001; ***, P < 0.005. (bottom) Representative pictures of H1792 cells from the same experiment stained for F-actin. Histograms in A-C represent means ± SEM. Bars, 10 µm.
